A major goal of the Immunology Core is to provide relevant immunologic assays for basic and clinical investigations of HIV and AIDS. The Core will be active in implementing the specific aims of the CFAR which include: 1) further understanding of the immunopathogenesis and pathogenesis of HIV infection and AIDS, 2) provide new approaches toward understanding cellular and humoral immune responses to HIV, 3) determine the effects of different anti-retroviral regimens on reconstitution of immunologic responses to HIV, 3) determine the effects of different anti-retroviral regimens on reconstitution of immunologic responses in HIV-infected subjects; 4) determine the effects of immunotherapy or gene therapy on reconstitution of immunologic responses ro al altering the clinical course in HIV=infected subjects receiving anti-retroviral therapy; 5) develop HIV vaccine strategies. To achieve these aims, standardized, quality-controlled assays of immune function are required to provide useful data for hypothesis testing. The overall goals for this Core are: 1) to provide basic immunology core laboratory support as required by CFAR investigators; 2) to develop new quality-assured assays necessary for CFAR protocols under development or anticipated; 3) to participate actively in the CFASR scientific agenda; 4) to develop standardized protocols for all assays performed in this Core; 5) to participate and demonstrate excellence in laboratory quality assurance and maintain a high standard of performance in established proficiency testing programs; and, 6) to further the understanding of the immunopathogenesis of HIV infection by analysis of data across protocols and by preparation of new concepts for future studies. This core has had substantial experience in cellular immunology research and AIDS research and has demonstrated scientific innovation through past and current scientific contributions.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI045008-04
Application #
6631224
Study Section
Project Start
2002-07-01
Project End
2003-06-30
Budget Start
Budget End
Support Year
4
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Gowda, Charitha; Lott, Stephen; Grigorian, Matthew et al. (2018) Absolute Insurer Denial of Direct-Acting Antiviral Therapy for Hepatitis C: A National Specialty Pharmacy Cohort Study. Open Forum Infect Dis 5:ofy076
Krump, Nathan A; Liu, Wei; You, Jianxin (2018) Mechanisms of persistence by small DNA tumor viruses. Curr Opin Virol 32:71-79
Coviello, D M; Lovato, R; Apostol, K et al. (2018) Prevalence of HIV Viral Load Suppression Among Psychiatric Inpatients with Comorbid Substance Use Disorders. Community Ment Health J :
Clarke, Erik L; Connell, A Jesse; Six, Emmanuelle et al. (2018) T cell dynamics and response of the microbiota after gene therapy to treat X-linked severe combined immunodeficiency. Genome Med 10:70
Ojikutu, Bisola O; Bogart, Laura M; Higgins-Biddle, Molly et al. (2018) Facilitators and Barriers to Pre-Exposure Prophylaxis (PrEP) Use Among Black Individuals in the United States: Results from the National Survey on HIV in the Black Community (NSHBC). AIDS Behav 22:3576-3587
Martei, Yehoda M; Pace, Lydia E; Brock, Jane E et al. (2018) Breast Cancer in Low- and Middle-Income Countries: Why We Need Pathology Capability to Solve This Challenge. Clin Lab Med 38:161-173
Wood, Sarah; Ratcliffe, Sarah; Gowda, Charitha et al. (2018) Impact of insurance coverage on HIV transmission potential among antiretroviral therapy-treated youth living with HIV. AIDS 32:895-902
Martin, Maureen P; Naranbhai, Vivek; Shea, Patrick R et al. (2018) Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1. J Clin Invest 128:1903-1912
Genn, Leah; Chapman, Jennifer; Okatch, Harriet et al. (2018) Pharmacy Refill Data are Poor Predictors of Virologic Treatment Outcomes in Adolescents with HIV in Botswana. AIDS Behav :
Shin, S S; Modongo, C; Zetola, N M et al. (2018) High rates of exposure to tuberculosis patients among HIV-infected health care workers in Botswana. Int J Tuberc Lung Dis 22:366-370

Showing the most recent 10 out of 775 publications